Minocycline Confers Early but Transient Protection in the Immature Brain following Focal Cerebral Ischemia—Reperfusion
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The incidence of neonatal stroke is high and currently there are no strategies to protect the neonatal brain from stroke or reduce the sequelae. Agents capable of modifying inflammatory processes hold promise. We set out to determine whether delayed administration of one such agent, minocycline, protects the immature brain in a model of transient middle cerebral artery (MCA) occlusion in 7-day-old rat pups. Injury volume in minocycline (45 mg/kg/dose, beginning at 2 h after MCA occlusion) and vehicle-treated pups was determined 24 h and 7 days after onset of reperfusion. Accumulation of activated microglia/macrophages, phosphorylation of mitogen-activated protein kinase (MAPK) p38 in the brain, and concentrations of inflammatory mediators in plasma and brain were determined at 24 h. Minocycline significantly reduced the volume of injury at 24 h but not 7 days after transient MCA occlusion. The beneficial effect of minocycline acutely after reperfusion was not associated with changed ED1 phenotype, nor was the pattern of MAPK p38 phosphorylation altered. Minocycline reduced accumulation of IL-1β and CINC-1 in the systemic circulation but failed to affect the increased levels of IL-1β, IL-18, MCP-1 or CINC-1 in the injured brain tissue. Therefore, minocycline provides early but transient protection, which is largely independent of microglial activation or activation of the MAPK p38 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317 · cited 1×
“For systematic random sampling of injury, the Gunderson coefficient of error (Gundersen et al, 1999) was used to estimate sampling error in analysis of volume of brain tissue and density of ED1 immunoreactive cells.”
MethodTetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · cited 4×
“…neurodegeneration have shown promising results (Arvin et al, 2002; Popovic et al, 2002; Teng et al, 2004; Thomas and Le, 2004; Thomas et al, 2003; Yrjanheikki et al, 1998, 1999; Zhu et al, 2002), while other studies show no protection (Diguet et al, 2004a, b) or even injury deterioration (Tsuji…”
BackgroundResultInfluentialTikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · cited 5×
“Minocycline effectively attenuates the delayed phase of injury after focal transient cerebral ischemia (Yrjanheikki et al, 1999) and global brain ischemia (Yrjanheikki et al, 1998) by reducing microglial activation and proliferation (Tikka et al, 2001a, b).”
BackgroundInfluentialInhibition of autoimmune encephalomyelitis by a tetracycline
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295 · cited 2×
“…to determine the protective effects of minocycline in experimental models of neurodegeneration have shown promising results (Arvin et al, 2002; Popovic et al, 2002; Teng et al, 2004; Thomas and Le, 2004; Thomas et al, 2003; Yrjanheikki et al, 1998, 1999; Zhu et al, 2002), while other studies…”
BackgroundResultDeleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease
Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Thomas, M., & Le, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453162 · Cited by 114 · cited 4×
“…of minocycline in experimental models of neurodegeneration have shown promising results (Arvin et al, 2002; Popovic et al, 2002; Teng et al, 2004; Thomas and Le, 2004; Thomas et al, 2003; Yrjanheikki et al, 1998, 1999; Zhu et al, 2002), while other studies show no protection (Diguet et al,…”
BackgroundResultInfluentialTikka, T., Usenius, T., Tenhunen, M., Keinänen, R., & Koistinaho, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00543.x · Cited by 96 · cited 5×
“Minocycline effectively attenuates the delayed phase of injury after focal transient cerebral ischemia (Yrjanheikki et al, 1999) and global brain ischemia (Yrjanheikki et al, 1998) by reducing microglial activation and proliferation (Tikka et al, 2001a, b).”
BackgroundInfluentialThomas, M., Le, W. D., & Jankovic, J. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200301000-00005 · Cited by 62 · cited 3×
“…various models of neurological diseases with chronic inflammatory components, such as models of Parkinson’s (Thomas and Le, 2004, 2003), Huntington’s (Thomas et al, 2003), multiple sclerosis (Popovic et al, 2002), ALS (Zhu et al, 2002) and in models of acute inflammation, such as brain trauma…”
BackgroundResult
Cited by
Czeh, M., Gressens, P., & Kaindl, A. M. (2011) · Developmental Neuroscience · doi:10.1159/000328989 · Cited by 321
Liu, Z., Fan, Y., Won, S. J., Neumann, M., Hu, D., Zhou, L., Weinstein, P. R., & Liu, J. (2007) · Stroke · doi:10.1161/01.str.0000251791.64910.cd · Cited by 291
Inflammatory responses in hypoxic ischemic encephalopathy
Liu, F., & Mccullough, L. D. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.89 · Cited by 283
Treatment advances in neonatal neuroprotection and neurointensive care
Johnston, M. V., Fatemi, A., Wilson, M. A., & Northington, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70016-3 · Cited by 278
Erickson, M. A., & Banks, W. A. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.06.006 · Cited by 261
Metadata
- Authors
- Fox, C., Dingman, A., Derugin, N., Wendland, M. F., Manabat, C., Ji, S., Ferriero, D. M., & Vexler, Z. S.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2005-09
- Volume
- 25
- Issue
- 9
- Pages
- 1138-1149
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2002886729
- Cited by
- 156
- References
- 10
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.